prod:prod_dcx-login
Xpert® MTB/RIF Ultra
Påvisning af Mycobacterium tuberculosis-kompleks og mutationer forbundet med rifampin-resistens på 80 minutter
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
50 Tests
GXMTB/RIF-ULTRA-50
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
10 Tests
GXMTB/RIF-ULTRA-10
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support
The Need
- Each day, close to 4,400 people lose their lives to TB and nearly 30,000 people fall ill with this preventable and curable disease1
- Globally, diagnosis of TB and drug-resistant TB remains a challenge, with a third of people with TB and two-thirds of people with drug-resistant TB not being detected1
- Precise and early detection of TB is needed to improve case management and significantly enhance the prevention of TB transmission2
(1) World Health Organization. Global Tuberculosis Report 2020. https://www.who.int/publications/i/item/9789240013131
(2) Kox. Tests for detection and identification of mycobacteria. How should they be used? Respir Med. 1995 Jul;89(6):399-408.;
(3) Diel et al. Cost-benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals. Eur Respir J. 2016 Feb;47(2):575-87.;
(4) Behr et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet. 1999 Feb 6;353(9151):444-9.
(2) Kox. Tests for detection and identification of mycobacteria. How should they be used? Respir Med. 1995 Jul;89(6):399-408.;
(3) Diel et al. Cost-benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals. Eur Respir J. 2016 Feb;47(2):575-87.;
(4) Behr et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet. 1999 Feb 6;353(9151):444-9.
The Solution
- Xpert MTB/RIF Ultra provides fast and highly accurate detection of Mycobacterium Tuberculosis (MTB) and Rifampicin (RIF) resistance simultaneously from patient samples
- Higher sensitivity, especially in smear-negative TB cases and among HIV-infected patients3
- Simple three-step process with minimal hands-on time and results in ~80 min direct from sample
- Designed to provide the most accurate MTB and Rifampicin detection utilizing multi-target and melt curves technology
- Accurate detection of mixed infections
(5) Jones M, et al. Xpert® MTB/RIF Ultra - design and analytical performance of a second generation Xpert® MTB/RIF assay. Poster presented at ECCMID. 2016 April 9-12, Amsterdam, Netherlands
The Impact
- Early detection of MTB and resistance to Rifampicin enables faster access to the most appropriate treatment for better patient outcomes4
- Increased access to front-line testing with Xpert MTB/RIF Ultra as part of active case finding and management can help limit community transmission5
- Superior performance of Xpert MTB/RIF Ultra versus smear microscopy enables more people with MTB infections to be detected and treated earlier4
(7) Global Laboratory Initiative. GLI model TB diagnostic algorithms. Accessed Mar 2017. http://www.stoptb.org/wg/gli/assets/documents/GLI_algorithms.pdf;
(8) World Health Organization. European Tuberculosis Laboratory Initiative. Algorithm for laboratory diagnosis and treatment-monitoring of pulmonary tuberculosis and drug-resistant tuberculosis using state-of-the-art rapid molecular diagnostic technologies. Accessed Mar 2017. http://www.euro.who.int/__data/assets/pdf_file/0006/333960/ELI-Algorithm.pdf;
(9) Global Laboratory Initiative. Planning for country transition to Xpert® MTB/RIF Ultra cartridges. Accessed Apr 2017. http://www.stoptb.org/wg/gli/assets/documents/GLI_ultra.pdf
(8) World Health Organization. European Tuberculosis Laboratory Initiative. Algorithm for laboratory diagnosis and treatment-monitoring of pulmonary tuberculosis and drug-resistant tuberculosis using state-of-the-art rapid molecular diagnostic technologies. Accessed Mar 2017. http://www.euro.who.int/__data/assets/pdf_file/0006/333960/ELI-Algorithm.pdf;
(9) Global Laboratory Initiative. Planning for country transition to Xpert® MTB/RIF Ultra cartridges. Accessed Apr 2017. http://www.stoptb.org/wg/gli/assets/documents/GLI_ultra.pdf
Related Products
Xpert HIV-1 Viral Load
Dual Target Detection for Extended Coverage and Superior Performance
Xpert HBV Viral Load
Detection and quantitation of Hepatitis B virus (HBV) in less than one hour
Xpert Xpress Flu/RSV
Accurate and reliable detection of Flu A, Flu B or RSV in as soon as 20 minutes*
Xpert Xpress Strep A
Qualitative real-time PCR test providing accurate detection of Group A Streptococcus in as soon as 18 minutes.*
Xpert HCV VL Fingerstick
Detection and quantitation of Hepatitis C virus (HCV) in about an hour
Xpert HIV-1 Qual
Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in around 90 minutes
Xpert Ebola
Accurate and Reliable Detection of Ebola Zaire Virus